Abstract:BACKGROUND: Inflammatory cytokines like interleukin-6 (IL-6) are implicated in depression, but most studies have hitherto focused on circulating levels of IL-6 rather than its activity. IL-6 trans-signalling is thought to be responsible for most of the pathogenic effects of IL-6 and is implicated in autoimmune diseases like rheumatoid arthritis. We tested the association between a multi-protein-derived measure of IL-6 trans-signalling and clinical and cognitive outcomes in patients with depression. We hypothesised that this novel measure of IL-6 activity/bioavailability would be associated with clinical and cognitive measures previously reported to be associated with inflammation in depression.METHODS: Using data from 86 patients with International Classification of Diseases-10 diagnosis of depression, we calculated a ratio score representing IL-6 activity/bioavailability using serum IL-6, soluble IL-6 receptor (sIL-6R), and soluble glycoprotein 130 levels. We tested the relationship of this novel biomarker with 12 cytokines using correlation analyses and with cognitive and clinical measures using multivariable linear regression, following z-transformation of all immune exposures.RESULTS: The novel measure of IL-6 activity/bioavailability was correlated with IL-6 (r=0.42, P=0.03), C-reactive protein (CRP) (r=0.42, P=0.03), sIL-6R (r=0.91, P<0.01), and tumour necrosis factor alpha (r=0.43, P=0.03). The IL-6 activity/bioavailability measure was associated with higher somatic symptoms of depression (β=1.09; 95% CI 0.30, 1.88; PFDR=0.01), fatigue (β=4.34; 95% CI 1.26, 7.42; PFDR=0.03), depression severity (β=3.06; 95% CI 0.71, 5.40; P=0.02), poorer quality of life (β=-0.07; 95% CI -0.13, -0.01; PFDR=0.045), and decreased psychomotor speed (β=-5.46; 95% CI -9.09, -1.84; PFDR=0.01),. There was little evidence of associations with reaction time, anhedonia, anxiety, emotional perception and recall, executive function, and sustained attention (Ps>0.05). The effect estimates for the associations of the novel measure with depression outcomes were comparable to those for individual immune proteins (i.e., IL-6, CRP, sIL-6R).CONCLUSION: A novel multi-protein-derived measure of IL-6 activity/bioavailability shows robust associations with various inflammation-related clinical and cognitive outcomes in depression and performs well in comparison to single inflammatory proteins. We need replication of these findings in other samples, experiments for mechanistic validity of this novel biomarker, and clinical studies to assess its usefulness as a marker of illness risk and prognosis.

Sex Difference in IL-6 Modulation of Cognition among Chinese Individuals with Major Depressive Disorder

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Gender Differences in Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with Major Depressive Disorder in China

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

Sex differences in the association of plasma cytokines and neurocognition in first-episode major depressive disorder

Increased Plasma Levels of IL-6 Are Associated with Striatal Structural Atrophy in Major Depressive Disorder Patients with Anhedonia

Differences in Inflammatory Marker Profiles and Cognitive Functioning Between Deficit and Nondeficit Schizophrenia

Gender Differences of Schizophrenia Patients with and Without Depressive Symptoms in Clinical Characteristics.

- Individuals with major depressive disorder and inflammation exhibited sex hormone imbalance: new insights from the Biomarker in Depression (BIODEP) study

The relationship between plasma interleukin-6 and cognition based on curve correlation in drug-naïve patients with major depressive disorder

Sex Differences in the Association Between Symptom Profiles and Cognitive Functioning in Patients with Depressive Disorder

Gender differences in brain region activation during verbal fluency task as detected by fNIRS in patients with depression.

Disturbed sex hormones milieu in males and females with major depressive disorder and low-grade inflammation

The comparison of sex differences in depression-like behaviors and neuroinflammatory changes in a rat model of depression model induced by chronic stress

Gender-related alterations of serum trace elements and neurometabolism in the anterior cingulate cortex of patients with major depressive disorder

Sex differences in subjective cognitive impairment and clinical correlates in Chinese patients with subthreshold depression

Inflammation and Cognitive Function in Overweight and Obese Chinese Individuals

Sex differences in a corticosterone-induced depression model in mice: Behavioral, neurochemical, and molecular insights

Association between inflammatory cytokines and symptoms of major depressive disorder in adults

A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression

Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder